Drugs/Procedures Used Patients taking low-dose aspirin without evidence of peptic ulcer disease at baseline endoscopy were randomized to famotidine 20 mg twice daily (n = 204) versus placebo twice ...

Last week, Zydus Lifesciences confirmed the receipt of an FDA warning letter at its Waghodia plant in Gujarat, India, marking ...

Zydus Lifesciences continues to be under intense scrutiny from the FDA, which hit the Indian drugmaker’s production facility in Jarod with a warning letter. Earlier this year, Zydus was slammed ...

Advt "This approval makes Zydus eligible for 180 days of exclusivity for Amantadine extended-release capsules (68.5 mg), it added. The Gujarat-based group said it now has 400 approvals from the USFDA.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

MUMBAI: Zydus Lifesciences Limited received the final nod from the United States Food and Drug Administration (USFDA) to market its Scopolamine Transdermal System, delivering 1 mg of the ...

(PTI) -Zydus Lifesciences on Saturday said it has inked a pact with Perfect Day Inc to acquire 50 per cent stake in Sterling Biotech. As part of the deal, Perfect Day Inc, a Temasek portfolio ...

Zydus Lifesciences Ltd announced today that its wholly-owned subsidiary, Zydus Animal Health and Investments Ltd, has completed the acquisition of a 50 per cent equity stake in Sterling Biotech ...

In the said exchange filing the company said, "Zydus Lifesciences conveyed this information through in exchange filing with the BSE. In the exchange filing, filed on September 17, the company said ...

Zydus Lifesciences Ltd through its wholly-owned subsidiary has signed an agreement to acquire a 50 per cent stake in Sterling Biotech Ltd (SBL) from Perfect Day Inc., a Temasek portfolio company.